PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Rhizome aqueous extract showed a maximum anti-inflammatory effect of 61.37% in a mice ear edema model [PMID:25850209].
Root extracts demonstrated cardioprotective and anti-apoptotic effects in isolated rat hearts [PMID:30419282, 34823510] and enhanced H9C2 myoblast viability [PMID:37525174].
Root extract was investigated for neuroprotective, antioxidative, anti-inflammatory, and antiapoptotic effects in a rat brain model [PMID:37642540].
Aqueous extracts of rhizome and aerial parts showed concentration-dependent cytotoxic effects (IC50: 280.51 and 310.79 μg/mL respectively) [PMID:24147362].
Extracts showed antiprotozoal activity against Tetrahymena pyriformis [PMID:36786997].
Evidence summary
PubMed sources
- 1.PMID: 33866888 (2022) — Six new triterpenoids from the root of Potentilla reptans and their cardioprotective effects in silico. · Natural product research
- 2.PMID: 37642540 (2023) — Neuroprotective effect of Potentilla reptans L. root in the rat brain global ischemia/reperfusion model. · Archiv der Pharmazie
- 3.PMID: 34823510 (2021) — Potentilla reptans L. postconditioning protects reperfusion injury via the RISK/SAFE pathways in an isolated rat heart. · BMC complementary medicine and therapies
- 4.PMID: 36786997 (2022) — New Plant Species Showing Antiprotozoian Activity. · Doklady. Biochemistry and biophysics
- 5.PMID: 24147362 (2013) — Cytotoxic effect of Potentilla reptans L. rhizome and aerial part extracts.